Compare RECT & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | RECT | RFL |
|---|---|---|
| Founded | 1997 | 2017 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.6M | 54.4M |
| IPO Year | 2024 | N/A |
| Metric | RECT | RFL |
|---|---|---|
| Price | $1.85 | $1.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.2K | ★ 143.0K |
| Earning Date | 07-31-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $32,594,177.00 | $1,029,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.61 | ★ N/A |
| Revenue Growth | 5.91 | ★ 47.63 |
| 52 Week Low | $1.79 | $1.17 |
| 52 Week High | $7.68 | $3.19 |
| Indicator | RECT | RFL |
|---|---|---|
| Relative Strength Index (RSI) | 27.15 | 45.00 |
| Support Level | $1.79 | $1.21 |
| Resistance Level | $2.12 | $1.60 |
| Average True Range (ATR) | 0.11 | 0.10 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 9.09 | 21.16 |
Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.